Join SenzaGen’s hosted session at 2021 SOT
Are you attending the 2021 SOT Annual Meeting and ToxExpo? Come join our workshop presentation, hosted session and poster presentations to hear the latest news about GARD™ and how the […]
Entries by Tina Dackemark Lawesson
SenzaGen’s CEO comments on the 2020 Year-end report
SenzaGen’s sales during the full year 2020 tripled compared to 2019. Listen to CEO Axel Sjöblad commenting the 2020 performance in today’s conference call. Listen to CEO comment
Watch our latest webinar recording!
Thanks to all who attended our webinar ‘Why choose GARD for skin sensitization testing?’ last week. If you were not able to attend live, and wish to watch it, you […]
Season’s greetings from all of us at SenzaGen
We wish you a truly happy holiday season, and we look forward to seeing you again in the new year. 2020 Highlights SenzaGen received GLP approval We can now offer […]
CEO presentation at Redeye Life Science Day
Our CEO Axel Sjöblad gave an update on our commercial progress at Redeye Life Science Day last week. Watch the replay here:
RIFM Principle Scientist Gretchen Ritacco speaks about SenzaGen and RIFM collaboration
Here is an interview with Principal Scientist Gretchen Ritacco, MS, explaining why RIFM has focused some of its research on the potential for light to activate fragrance materials resulting in […]
Webinar: Safer Medical Devices
Safer Medical Devices – in vitro skin sensitization testing with human relevance and high accuracy By Rose-Marie Jenvert, PhD, and Joshua Schmidt, PhD, SenzaGen Watch by clicking the image below.
The GARDpotency assay for potency-associated subclassification of chemical skin sensitizers – Rationale, method development and ring trial results of predictive performance and reproducibility
Toxicological Sciences, kfaa068, https://doi.org/10.1093/toxsci/kfaa068 Robin Gradin, Angelica Johansson, Andy Forreryd, Emil Aaltonen, Anders Jerre, Olivia Larne, Ulrika Mattson, Henrik Johansson Abstract Proactive identification and characterization of hazards attributable to chemicals […]
Watch our latest GARDskin Dose-Response Webinar
Thanks to all who attending yesterday’s GARDskin Dose-Response webinar. If you missed it, here’s a link to the recording.
CEO presentation at AGM 2020
Comments to the 2019 closing and 2020 update by CEO Axel Sjöblad.
